The Effectivity of Losartan Tablet for Decreasing Fibrotic Tissue Formation in Gastrocnemius Muscle Injury Grade I of Rabbits

The Effectivity of Losartan Tablet for Decreasing Fibrotic Tissue Formation in Gastrocnemius Muscle Injury Grade I of Rabbits

ABSTRACT Muscle injuries among athletes require a complete recovery to be able to function optimally as before. However, in spite of implementing the management with PRICE (Protection, Rest, Immobilization, Compression and Elevation), during the recovery processes, fibrotic tissue will be formed,...

Full description

Bibliographic Details
Main Authors:	Boby Harul Priono, Hermawan Rasyid, Yoyos Ismiarto, Ahmad Ramdan
Format:	Article
Language:	English
Published:	Universitas Indonesia 2019-04-01
Series:	Pharmaceutical Sciences and Research
Subjects:	fibrotic h-score losartan muscle injury grade 1
Online Access:	http://www.psr.ui.ac.id/index.php/journal/article/view/4256

Similar Items

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
by: Shahid Sarwar, et al.
Published: (2012-12-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
by: Zhenhan Deng, et al.
Published: (2022-06-01)

Determining the Effects of Morphine, Heroin, and Losartan and the Interaction of each on Losartan in Water Homeostasis Mechanisms by the Kidney in Adult Male Rabbits
by: F Foroohi, et al.
Published: (2015-04-01)

Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results
by: Kamran Ahmad Khan, et al.
Published: (2024-01-01)

Design and Evaluation of Losartan Potassium Effervescent Floating Matrix Tablets: In Vivo X-ray Imaging and Pharmacokinetic Studies in Albino Rabbits
by: Mohamed Rahamathulla, et al.
Published: (2021-10-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015-03-01)

Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
by: Arian Amirkhosravi, et al.
Published: (2024-04-01)

Validation of a UV spectrophotometric method to quantify losartan potassium in tablets from the dissolution test at pH 1.2, 4.5 and 6.8
by: Antonella S. Araujo-Fernandez, et al.
Published: (2022-03-01)

Drug-Induced Liver Injury Due To Losartan
by: Joana Diogo, et al.
Published: (2021-11-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
by: Valentinë Elezaj, et al.
Published: (2022-03-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
by: EDNA GOMEZ ORTIZ, et al.
Published: (2014-01-01)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Comparison of the GPVI inhibitors losartan and honokiol
by: Marie-Blanche Onselaer, et al.
Published: (2020-02-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
by: Noelle Castilla‐Ojo, et al.
Published: (2023-10-01)

Fibrotic hypersensitivity pneumonitis
by: Ravindran Chetambath, et al.
Published: (2023-01-01)

Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats
by: Farahnaz Jazaeri, et al.
Published: (2018-02-01)

Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin
by: Hyosang Kim, et al.
Published: (2017-01-01)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
by: Hyeon A Kim, et al.
Published: (2023-09-01)

Investigations on Synperiplanar and Antiperiplanar Isomers of Losartan: Theoretical and Experimental NMR Studies
by: Jacek Kujawski, et al.
Published: (2015-06-01)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
by: Gabriel Mulinari-Santos, et al.

Synergistic effects of sitagliptin and losartan against fipronil-induced hepatotoxicity in rats
by: Sara T. Elazab, et al.
Published: (2021-07-01)

COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
by: Akhmad Kharis Nugroho, et al.
Published: (2014-01-01)

Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
by: Jin Seong Hyeon, et al.
Published: (2020-11-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Changes of and genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
by: Hyeryon Lee, et al.
Published: (2019-03-01)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
by: Qing Li, et al.
Published: (2022-11-01)

Losartan-induced ischemic hepatocellular hepatotoxicity: A case report and literature review
by: Moh′d Z Al-Halawani, et al.
Published: (2014-01-01)

Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
by: Aakriti Garg Shukla, et al.
Published: (2023-04-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 3; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2024-02-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 2; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2023-05-01)